SCHEDULE: FIL Limited Reports 0% Stake in ZEPP Health Corp

Sentiment:

Beneficial Ownership Report


FIL Limited and its affiliates have filed an amended Schedule 13G, reporting no beneficial ownership in ZEPP Health Corp's Class A Common Stock as of July 31, 2025.

Summary

  • FIL Limited, Pandanus Partners, L.P., and Pandanus Associates, Inc. have filed an Amendment No. 7 to Schedule 13G concerning ZEPP HEALTH CORP.
  • The filing reports 0.00 shares beneficially owned in ZEPP HEALTH CORP's Class A Common Stock by the reporting persons.
  • This represents 0.0% of the total Class A Common Stock outstanding.
  • The event date requiring this filing was July 31, 2025.
  • The filing is made under Rule 13d-1(c) of the Securities Exchange Act of 1934.
  • FIL Limited is organized in Bermuda, while Pandanus Partners, L.P. and Pandanus Associates, Inc. are organized in Delaware.
  • Pandanus Partners, L.P. owns voting stock in FIL Limited, typically representing between 25% and 48.5% of the total votes.
  • Pandanus Associates, Inc. acts as the general partner of Pandanus Partners, L.P.
  • Pandanus is owned by trusts for the benefit of members of the Johnson family, including FIL's Chairman Abigail P. Johnson, who disclaim beneficial ownership of the reported securities.

Sentiment

Score: 5

Explanation: The filing is a routine regulatory disclosure (Schedule 13G) reporting 0% beneficial ownership, indicating a neutral impact on the company's sentiment as it does not convey new financial performance or strategic developments.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

  • Pandanus Partners, L.P. owns voting stock in FIL Limited, typically representing between 25% and 48.5% of total votes.
  • Pandanus Associates, Inc. acts as the general partner of Pandanus Partners, L.P.
  • Pandanus Partners, L.P. is owned by trusts for the benefit of members of the Johnson family, including FIL's Chairman Abigail P. Johnson, though these individuals disclaim beneficial ownership of the reported securities.

Stakeholder Impact

  • Minimal direct impact on shareholders as the filing reports no beneficial ownership by the reporting entities, indicating no change in their stake.
  • No direct impact on employees, customers, suppliers, or creditors as the filing is purely a beneficial ownership disclosure.

Key Dates

DateDescription
2023-05-23Effective date of Power of Attorney for Richard Bourgelas, authorizing signatures on behalf of the reporting entities.
2024-07-10Date of previous Schedule 13G filing by FIL Limited, referenced for Power of Attorney accession number.
2025-07-31Date of event which requires the filing of this statement.
2025-08-06Date of signing of this Schedule 13G Amendment No. 7.

Keywords

ZEPP HEALTH CORP, FIL Limited, Schedule 13G, Beneficial Ownership, Class A Common Stock, Pandanus Partners, Pandanus Associates, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.